Diagenode
| United States | My cart | 登录 / 注册 搜索

News

CRISPR/Cas9 press release
September 23, 2015

Diagenode’s CRISPR/Cas9 polyclonal antibody has been raised against the N-terminus of the Cas9 nuclease, extensively validated and optimized for excellent specificity and high yields in chromatin IP.

Read more

活动

  • American Association of Cancer Research (AACR)
    Chicago (IL), USA
    Apr 25-Apr 30, 2025
  • 14th International Symposium on Minimal Residual Cancer
    Nice, France
    May 7-May 9, 2025
 查看所有活动

 

       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy